Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for AZTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 4.724M
March 31, 2026 -114.75M
December 31, 2025 36.77M
September 30, 2025 0.826M
June 30, 2025 -29.70M
March 31, 2025 -138.67M
December 31, 2024 77.09M
September 30, 2024 198.01M
June 30, 2024 199.74M
March 31, 2024 -272.03M
December 31, 2023 99.02M
September 30, 2023 102.49M
June 30, 2023 214.37M
March 31, 2023 58.17M
December 31, 2022 56.36M
September 30, 2022 -374.48M
June 30, 2022 31.87M
March 31, 2022 1.827B
December 31, 2021 -18.42M
September 30, 2021 -17.52M
June 30, 2021 -101.45M
March 31, 2021 2.909M
December 31, 2020 -30.29M
September 30, 2020 -10.19M
June 30, 2020 -8.515M
Date Value
March 31, 2020 -17.27M
December 31, 2019 13.23M
September 30, 2019 619.39M
June 30, 2019 -5.872M
March 31, 2019 -3.61M
December 31, 2018 -398.60M
September 30, 2018 -6.509M
June 30, 2018 -22.04M
March 31, 2018 -25.57M
December 31, 2017 -94.35M
September 30, 2017 -45.20M
June 30, 2017 1.676M
March 31, 2017 -1.385M
December 31, 2016 -9.284M
September 30, 2016 -0.458M
June 30, 2016 -4.325M
March 31, 2016 -0.779M
December 31, 2015 -5.312M
September 30, 2015 -4.965M
June 30, 2015 -3.66M
March 31, 2015 0.56M
December 31, 2014 -9.572M
September 30, 2014 -23.57M
June 30, 2014 29.30M
March 31, 2014 -15.20M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. -1.032B
Bio-Rad Laboratories, Inc. -66.70M
Bruker Corp. -25.30M
Danaher Corp. -10.15B
Harvard Bioscience, Inc. -0.916M